Xylia evansii

Xylia evansii · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Xylia evansii is a significant botanical species frequently studied for its diverse pharmacological potential. Recent scientific investigations have focused on the plant's efficacy in addressing various medical challenges, particularly the management of Schistosomiasis. To explore these therapeutic properties, researchers utilize specialized methanol extracts derived from the plant's tissues. These concentrated preparations serve as the primary medium for identifying bioactive compounds capable of combating parasitic infections. Understanding the chemical profile of these extracts provides vital insights into the plant's role in traditional and modern medicine.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Fabaceae
Distribution
Africa
Plant Parts
Not available

Classification

Taxonomy

Xylia evansii is a distinct biological entity belonging to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida and the order Fabales. As a member of the Fabaceae family, it shares characteristics with many other influential legumes. This specific plant is further identified by its unique classification within the genus Xylia. Understanding these taxonomic relationships provides essential insight into its evolutionary place in the natural world.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Fabales
Family Fabaceae
Genus Xylia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Xylia evansii is a notable tree species primarily found throughout the West Tropical Africa region. Its natural distribution spans several key countries, including Ghana and Guinea, where it plays a role in the local ecosystem. The species also thrives within the tropical landscapes of the Ivory Coast and Liberia. Furthermore, its presence is well-documented across the forests of Sierra Leone. This widespread occurrence across these specific nations highlights its importance to the biological diversity of West Africa.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Xylia evansii is a self-supporting tree that maintains a robust and sturdy structural form. This species reaches a maximum height of 25 meters as it matures in its natural habitat. Its distinctive growth form makes it a prominent feature within its ecosystem.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Conditions

Xylia evansii is recognized for its medicinal potential in treating schistosomiasis through its cercaricidal activity. In an ethnobotanical study conducted in Ghana, methanol extracts of this plant were tested against human Schistosoma mansoni cercariae. The research demonstrated that the plant exhibits time- and concentration-dependent lethality against the parasites. Specifically, Xylia evansii showed significant potency with an LC50 value of 11.14. These findings provide scientific support for the traditional use of the species in managing this endemic disease.

Preparations

Xylia evansii is prepared as methanol extracts to evaluate its potential cercaricidal activity against Schistosoma mansoni. In the study conducted in the Atwima-Nwabiagya District, these specific extracts were tested for their ability to kill cercariae. The research demonstrated that the methanol extracts of this plant exhibit time- and concentration-dependent lethality. Among the nine plants tested, Xylia evansii showed significant potency with an LC50 value of 11.14 μg/mL. This preparation method allowed researchers to scientifically validate the medicinal properties of the plant's extracts.

Parts used